Plan sponsors are encouraged to evaluate this cost-effective alternative, balancing it with regulatory considerations and the long-term needs of their members
Mischley LK, Standish LJ, Weiss NS, Padowski JM, Kavanagh TJ, White CC, et al
For men who prefer a more natural, minimal approach, its an easy way to get both protection and subtle coverage in one step
If youre interested in exploring Wegovy or other weight loss medications, we encourage you to take our free assessment quiz to see if you qualify for our prescription programs
If they notice less bloating and other symptoms, such as sniffling, sneezing, headaches, rashes, diarrhea, abdominal pain, or itching, they may have discovered a histamine intolerance
Viatris lawsuit is the one to watch 20312033: Most analysts' baseline forecast for final FDA approval and US market launch, assuming patents run their course 20332036: More conservative estimates accounting for remaining IP layers What could change this timeline: Further successful patent challenges by generic manufacturers Congressional or executive action to accelerate generic biologics access Expanded FDA streamlining of the biosimilar approval pathway For now, the cost relief available globally in 2026 will not reach US patients through the generic or biosimilar route